Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PC | P11498 | 6/20 | 1.00 |
| ▸ | F3 | P13726 | 3/20 | 0.65 |
| ▸ | XDH | P47989 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.52 |
| ▸ | GLS | O94925 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23983781 | 1.00 | PC (1.00) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL25993869 | 1.00 | PC (1.00) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL30543004 | 1.00 | PC (1.00) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL22567668 | 1.00 | PC (1.00) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL23983782 | 1.00 | PC (1.00) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL25817542 | 0.97 | PC (0.95) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL31256542 | 0.96 | PC (0.92) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL24486419 | 0.94 | PC (0.88) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL25993944 | 0.94 | PC (0.88) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL30341014 | 0.90 | PC (0.82) | PCF3XDHPTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12257260-B2 | Pharmaceutical use of anemoside B4 against acute gouty arthritis | LIU QI (CN) | 2025-03-25 | — | — | US | claimed |
| US-11865129-B2 | Application of anemoside B4 in preparation of a drug for treatment or prevention of psoriasis | Guangxi Xinhai Pharmaceutical Technology Co., Ltd. (CN) | 2024-01-09 | — | — | US | claimed |
| US-20230201230-A1 | APPLICATION OF ANEMOSIDE B4 IN PREPARATION OF A DRUG FOR TREATMENT OR PREVENTION OF PSORIASIS | Guangxi Xinhai Pharmaceutical Technology Co., Ltd. (CN) | 2023-06-29 | — | — | US | claimed |
| EP-4201409-A1 | APPLICATION OF ANEMOSIDE B4 IN PREPARATION OF A DRUG FOR TREATMENT OR PREVENTION OF PSORIASIS | Guangxi Xinhai Pharmaceutical Technology Co., Ltd (CN) | 2023-06-28 | — | — | EP | claimed |
| US-20230102973-A1 | Medical Use of Anemoside B4 in the Treatment of Oral Ulcers | LIU QI (CN) | 2023-03-30 | — | — | US | claimed |
| US-11510933-B2 | Use of Pulsatilla chinensis extract in the preparation of drugs for treatment of viral and/or bacterial diseases | SICHUAN INLU WEITE PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2022-11-29 | — | — | US | claimed |
| US-12257260-B2 | Pharmaceutical use of anemoside B4 against acute gouty arthritis | LIU QI (CN) | 2025-03-25 | — | — | US | disclosed |
| US-12257260-B2 | Pharmaceutical use of anemoside B4 against acute gouty arthritis | LIU QI (CN) | 2025-03-25 | — | — | US | disclosed |
| US-12257260-B2 | Pharmaceutical use of anemoside B4 against acute gouty arthritis | LIU QI (CN) | 2025-03-25 | — | — | US | disclosed |
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | SOOCHOW UNIVERSITY (CN) | 2025-02-27 | — | — | US | disclosed |
| EP-4201409-B1 | ANEMOSIDE B4 FOR USE IN THE TREATMENT OF PSORIASIS | GUANGXI XINHAI PHARMACEUTICAL TECH CO LTD (CN) | 2024-09-25 | — | — | EP | disclosed |
| EP-3868383-B1 | PHARMACEUTICAL USE OF ANEMOSIDE B4 AGAINST ACUTE GOUTY ARTHRITIS | LIU QI (CN) | 2024-06-12 | — | — | EP | disclosed |
| EP-3868383-C0 | PHARMACEUTICAL USE OF ANEMOSIDE B4 AGAINST ACUTE GOUTY ARTHRITIS | LIU QI (CN) | 2024-06-12 | — | — | EP | disclosed |
| CN-113499326-B | Pulsatillae saponin B4 atomization inhalation preparation and application | 广西馨海药业科技有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114681475-A | Application of pulsatilla saponin B4 in preparation of medicine or health-care food for preventing, relieving or treating sarcopenia | 中国中医科学院中药研究所 | 2022-07-01 | — | — | CN | disclosed |
| CN-114652732-A | Application of pulsatilla saponin B4 in preparation of medicine for treating impotence | 中国中医科学院中药研究所 | 2022-06-24 | — | — | CN | disclosed |
| CN-110090221-B | Application of pulsatilla chinensis extract in preparation of medicines for treating viral and/or bacterial diseases | 广西英路维特药物有限公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-110090222-B | Application of pulsatilla chinensis extract in preparation of medicines for treating viral and/or bacterial diseases | 广西英路维特药物有限公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-114191442-A | Application of pulsatilla saponin B4 in preparation of medicine for treating wet macular degeneration | 中国中医科学院中药研究所 | 2022-03-18 | — | — | CN | disclosed |
| CN-112569190-B | Oral administration preparation of pulsatilla chinensis saponin B4 and preparation method thereof | 苏州大学 | 2022-03-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11865129-B2 | Application of anemoside B4 in preparation of a drug for treatment or prevention of psoriasis | IL17A, IL4, TNF | PC 2926/4885F3 878/4885XDH 3313/4885 |
| US-20230102973-A1 | Medical Use of Anemoside B4 in the Treatment of Oral Ulcers | LTB4R2, LTB4R, APRT | PC 3837/4885F3 2437/4885XDH 1468/4885 |
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | CASP4, CASP3, CASP14 | PC 467/4885F3 1031/4885XDH 737/4885 |
| US-11510933-B2 | Use of Pulsatilla chinensis extract in the preparation of drugs for treatment of viral and/or bacterial diseases | ATP6V1B1, PKD1, ALPP | PC 1651/4885F3 53/4885XDH 3654/4885 |
| US-12257260-B2 | Pharmaceutical use of anemoside B4 against acute gouty arthritis | ABCB4, ATP6V1B1, UGT2B7 | PC 1565/4885F3 3051/4885XDH 425/4885 |
| US-20230201230-A1 | APPLICATION OF ANEMOSIDE B4 IN PREPARATION OF A DRUG FOR TREATMENT OR PREVENTION OF PSORIASIS | IL17A, IL4, TNF | PC 2926/4885F3 878/4885XDH 3313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.